These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 30367322)

  • 1. Classification of contrast-enhanced spectral mammography (CESM) images.
    Perek S; Kiryati N; Zimmerman-Moreno G; Sklair-Levy M; Konen E; Mayer A
    Int J Comput Assist Radiol Surg; 2019 Feb; 14(2):249-257. PubMed ID: 30367322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding the power of iodinated contrast media to the credibility of mammography in breast cancer diagnosis.
    Tsigginou A; Gkali C; Chalazonitis A; Feida E; Vlachos DE; Zagouri F; Rellias I; Dimitrakakis C
    Br J Radiol; 2016 Nov; 89(1067):20160397. PubMed ID: 27452266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-aided diagnosis of contrast-enhanced spectral mammography: A feasibility study.
    Patel BK; Ranjbar S; Wu T; Pockaj BA; Li J; Zhang N; Lobbes M; Zhang B; Mitchell JR
    Eur J Radiol; 2018 Jan; 98():207-213. PubMed ID: 29279165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.
    Travieso-Aja MDM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Vega Benítez V; Pérez-Luzardo O
    Radiol Med; 2019 Oct; 124(10):1006-1017. PubMed ID: 31250270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiview multimodal network for breast cancer diagnosis in contrast-enhanced spectral mammography images.
    Song J; Zheng Y; Zakir Ullah M; Wang J; Jiang Y; Xu C; Zou Z; Ding G
    Int J Comput Assist Radiol Surg; 2021 Jun; 16(6):979-988. PubMed ID: 33966155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of routine use of breast ultrasound following contrast-enhanced spectral mammography.
    Klang E; Krosser A; Amitai MM; Sorin V; Halshtok Neiman O; Shalmon A; Gotlieb M; Sklair-Levy M
    Clin Radiol; 2018 Oct; 73(10):908.e11-908.e16. PubMed ID: 30041953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of contrast-enhanced spectral mammography for intramammary cancer staging: preliminary results.
    Blum KS; Rubbert C; Mathys B; Antoch G; Mohrmann S; Obenauer S
    Acad Radiol; 2014 Nov; 21(11):1363-9. PubMed ID: 25127846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A deep learning approach for virtual contrast enhancement in Contrast Enhanced Spectral Mammography.
    Rofena A; Guarrasi V; Sarli M; Piccolo CL; Sammarra M; Zobel BB; Soda P
    Comput Med Imaging Graph; 2024 Sep; 116():102398. PubMed ID: 38810487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Luczyńska E; Heinze S; Adamczyk A; Rys J; Mitus JW; Hendrick E
    Anticancer Res; 2016 Aug; 36(8):4359-66. PubMed ID: 27466557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of suspicious calcification in the diagnosis and surgical treatment of breast lesions using contrast-enhanced spectral mammography].
    Sun XF; Xing W; Yu SN; Sha YY; Pan L; Chen Q
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(1):42-46. PubMed ID: 31914557
    [No Abstract]   [Full Text] [Related]  

  • 12. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits.
    Houben IPL; Van de Voorde P; Jeukens CRLPN; Wildberger JE; Kooreman LF; Smidt ML; Lobbes MBI
    Eur J Radiol; 2017 Sep; 94():31-37. PubMed ID: 28941757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
    Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
    J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the classification ability of network utilizing fusion technique in contrast-enhanced spectral mammography.
    Song J; Zheng Y; Xu C; Zou Z; Ding G; Huang W
    Med Phys; 2022 Feb; 49(2):966-977. PubMed ID: 34860417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced spectral mammography (CESM) in women presenting with palpable breast findings.
    Sorin V; Faermann R; Yagil Y; Shalmon A; Gotlieb M; Halshtok-Neiman O; Ben-David MA; Sklair-Levy M
    Clin Imaging; 2020 May; 61():99-105. PubMed ID: 32014818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
    Liew ALF; Lim HMY; Fok ECM; Loke SC; Tan EY; Chong BK; Lee YS; Chan PMY; Chotai N
    Breast J; 2022; 2022():7087408. PubMed ID: 35711887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results.
    Łuczyńska E; Niemiec J; Hendrick E; Heinze S; Jaszczyński J; Jakubowicz J; Sas-Korczyńska B; Rys J
    Med Sci Monit; 2016 Oct; 22():3886-3893. PubMed ID: 27768681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Assessment of Contrast Enhancement on Contrast Enhancement Spectral Mammography (CESM) and Comparison With Qualitative Assessment.
    Rudnicki W; Heinze S; Popiela T; Kojs Z; Luczynska E
    Anticancer Res; 2020 May; 40(5):2925-2932. PubMed ID: 32366444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumours.
    Dominique C; Callonnec F; Berghian A; Defta D; Vera P; Modzelewski R; Decazes P
    Eur Radiol; 2022 Jul; 32(7):4834-4844. PubMed ID: 35094119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study.
    Lalji UC; Houben IP; Prevos R; Gommers S; van Goethem M; Vanwetswinkel S; Pijnappel R; Steeman R; Frotscher C; Mok W; Nelemans P; Smidt ML; Beets-Tan RG; Wildberger JE; Lobbes MB
    Eur Radiol; 2016 Dec; 26(12):4371-4379. PubMed ID: 27097789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.